Independent Research
SLS Analysis
4 pieces of research on SELLAS Life Sciences Group, Inc.. We find the signal management buried in the earnings call.
3signal analyses
1news briefs
latest: Oct 28, 2026
Signal Analysis (2)
Analysis
SELLAS CEO Claims GPS Has 'Very Good Chance' to Beat AML
CEO Angelos Stergiou has stated GPS has a "very good chance" to beat prior survival outcomes, with SELLAS's $2.42 billion valuation staked almost entirely on th…
Read analysis →Analysis
SELLAS AML Readout Two Events Away as Retail Bets Surge
SELLAS Life Sciences is two death events away from final analysis on its Phase 3 AML trial, the sole catalyst for the stock. While retail investors bid the stoc…
Read analysis →